http://orcid.org/0000-0002-9979-2444
REFERENCES
- Barsky, A. J., S. L. Ettner, J. Horsky, and D. W. Bates. 2001. Resource utilization of patients with hypochondriacal health anxiety and somatization. Medical Care 39(7): 705–715.
- Barsky, A. J., R. Saintfort, M. P. Rogers, and J. F. Borus. 2002. Nonspecific medication side effects and the nocebo phenomenon. Journal of the American Medical Association 287(5): 622–627.
- Cohen, S. 2014. The nocebo effect of informed consent. Bioethics 28(3): 147–154.
- Cruz, M. D L, D. Hui, H. A. Parsons, and E. Bruera. 2010. Placebo and nocebo effects in randomized double-Blind Clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer 116(3): 766–774.
- Fortunato, J. T., J. A. Wasserman, and D. L. Menkes. 2017. When respecting autonomy is harmful: A clinically useful approach to the nocebo effect. American Journal of Bioethics 17(6): 36–42.
- Gligorov, N. 2018. Telling the truth about pain: Informed consent and the role of expectation in pain intensity. AJOB Neuroscience 9(3): XX–XX.
- Hahn, R. A. 1997. The nocebo phenomenon: Concept, evidence, and implications for public health. Preventive Medicine 26(5): 607–611.
- Harkins, S. W., D. D. Price, and J. Braith. 1989. Effects of extraversion and neuroticism on experimental pain, clinical pain, and illness behavior. Pain 36(2): 209–218.
- Wells, R. E., and T. J. Kaptchuk. 2012. To tell the truth, the whole truth, may do patients harm: The problem of the nocebo effect for informed consent. American Journal of Bioethics 12(3): 22–29.